Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00442104 · ClinicalTrials.gov registry record · Phase 2
Open-label Extension to Protocol 1042-0500
A Phase 2 study, sponsored by Marinus Pharmaceuticals.
- Terminated
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT00442104 is a Phase 2 study that was terminated before completion, run by Marinus Pharmaceuticals. The registered enrollment target is 54 participants.
The verdict
NCT00442104, a Phase 2 study, was terminated before completion, sponsored by Marinus Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
To allow open-label extension to patients who have completed Protocol 1042-0500
Interventions
- DRUG Ganaxolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00442104
The ClinicalTrials.gov registry entry for NCT00442104 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marinus Pharmaceuticals, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ganaxolone is the first listed.
NCT00442104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00442104 about?
NCT00442104 is a clinical study titled "Open-label Extension to Protocol 1042-0500". To allow open-label extension to patients who have completed Protocol 1042-0500
What is the current status of trial NCT00442104?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2007-01. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00442104?
The interventions under investigation include: Ganaxolone (DRUG).
Who is sponsoring clinical trial NCT00442104?
This trial is sponsored by Marinus Pharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.